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Abstract
The cell membrane is protected against lipid peroxidation by endogenous antioxidants such as vitamin E (-tocopherol). The oxidised
form of a-tocopherol (a-tocopherol quinone) does not have this antioxidant function. However, the literature indicates thata-tocopherol
quinone can be reduced toa-tocopherolin vivo and thereby will add to the total antioxidant potential (Moore AN, Ingold KU. Free Radic
Biol Med 1997;22:931–4). We found that GSH (reduced glutathione) did not mediate the reduction ofa-toc pherol quinone, either directly
in solution or in rat liver microsomes fortified witha-tocopherol quinone. This renders GSH a less likely candidate fora-t copherol quinone
reductionin vivo. In addition,a-tocopherol quinone did not enhance GSH-dependent protection against lipid peroxidation, either in control
microsomes, or in vitamin E-extracted microsomes. Indeed,a-tocopherol quinone blocked GSH-dependent protection against lipid
peroxidation in vitamin E-extracted microsomes. This indicates thata-tocopherol quinone can act as a pro-oxidant. © 2001 Elsevier Science
Inc. All rights reserved.
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1. Introduction
Reactive oxygen species (ROS) play an important role in
diseases such as cancer and cardiovascular and pulmonary
disorders. They are formed continuously, e.g. by the cyto-
chrome P450 system located in the microsomes (endoplas-
mic reticulum) in hepatocytes. Like all biomembranes, mi-
crosomes are susceptible to damage by ROS. In particular,
polyunsaturated fatty acids in the membrane are vulnerable
to lipid peroxidation. These polyunsaturated fatty acids are
protected against peroxidation by antioxidants such asa-to-
copherol and reduced glutathione (GSH). Lipid-soluble
a-tocopherol functions as a chain-breaking antioxidant.
Radicals that are formed during lipid peroxidation may
abstract a hydrogen atom from the OH moiety ofa-tocoph-
erol. In this way, radicals in the lipid bilayer are made
inactive anda-tocopherol radicals are formed. The latter
can be further oxidised toa-tocopherol quinone, which does
not function as an antioxidant because it lacks the OH
moiety [1,2]. Moore and Ingold have shown [3] thata-to-
copherol quinone is converted toa-tocopherolin vivo. This
implies thata-tocopherol quinone may indirectly contribute
to the antioxidant statusin vivo.
GSH protects against lipid peroxidation in cooperation
with vitamin E [1,2,4–7]. It has been reported thata-to-
copherol is regenerated from thea-tocopherol radical by a
microsomal GSH-dependent free radical reductase (inset in
Fig. 1) [1,2,4,8]. In the present study, the recycling of
a-tocopherol froma-tocopherol quinone by GSH was ex-
amined both after direct interaction and under conditions
wherea-tocopherol quinone was present in the liver micro-
somal membrane. Liver microsomes were chosen since: (a)
they contain an important radical-producing system; (b) the
a-tocopherol content is high; and (c) once thea-tocopherol
has been oxidised, the lipophilica-tocopherol quinone is
likely to be retained within the microsomes. Moreover, the
microsomes contain a free radical reductase that converts
the a-tocopherol radical toa-tocopherol at the expense of
GSH [1,2,4,8]. Possibly this or another microsomal enzyme
might be involved in a GSH-dependent reduction ofa-to-
copherol quinone toa-tocopherol. The effect ofa-tocoph-
erol quinone on the protection by GSH against lipid peroxi-
dation was also studied.
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2. Materials and methods
2.1. Chemicals
GSH anda-tocopherol quinone were obtained from ICN
Biomedicals, andD-a-tocopherol was obtained from Sigma.
All other chemicals used were of analytical grade purity.
2.2. Chemical reduction ofa-tocopherol quinone
a-Tocopherol quinone (0.1 mM) was incubated with
GSH (0.1, 1, and 10 mM) at 25° in potassium phosphate
buffer (10 mM, pH 7.4, total volume 0.6 mL). The change
in the absorption spectra over time was monitored to study
the reduction ofa-tocopherol quinone toa-tocopherol.
2.3. Microsomes
Microsomes were prepared from male Lewis rats (CPV,
Maastricht University, Maastricht, The Netherlands), 200–
250 g. After decapitation, the livers were removed and
homogenised (1:2, w/v) in ice-cold potassium phosphate
buffer (50 mM, pH 7.4) containing 0.1 mM EDTA. The
homogenate was centrifuged at 10,0003 g (20 min at 4°).
Subsequently, the supernatant was centrifuged at 10,0003
g (20 min at 4°) and again at 65,0003 g (60 min at 4°). The
microsomal pellet was resuspended in the phosphate buffer
(2 g liver/mL) and stored at280°. Before use, the control
microsomes were thawed and washed twice (centrifugation
at 115,0003 g, 40 min) with ice-cold Tris–HCl buffer (50
mM, pH 7.4) containing 150 mM KCl.
a-Tocopherol was extracted from the microsomes ac-
cording to Maiorinoet al. [9]. In short, the stored micro-
somes were thawed and mixed with 2 volumes of ice-cold
acetone and shaken vigorously. After 5 min, the micro-
somes were washed twice with centrifugation at 115,0003
g (40 min at 4°). Care was taken to remove all the acetone,
since it is known that acetone interferes with the method
used to detect lipid peroxidation (i.e. acetone reacts with
thiobarbituric acid). The pellet obtained after centrifugation
of the microsomes was resuspended in ice-cold Tris–HCl
buffer.a-Tocopherol quinone was added to the microsomes
after the extraction with acetone. The microsomes were
mixed vigorously for 1 min and washed twice (centrifuga-
tion at 115,0003 g, 40 min at 4°) with ice-cold Tris–HCl
buffer.
2.4. Reduction ofa-tocopherol quinone in microsomes
a-Tocopherol quinone (0.55mM final concentration) and
an excess of GSH (1 mM final concentration) was added to
microsomes (2 g liver/mL) and shaken vigorously. The
microsomes were incubated by shaking (190 rpm, 37°), air
being freely admitted, and thea-tocopherol quinone and
a-tocopherol were determined using HPLC.
2.5. Lipid peroxidation assay
Microsomes (final concentration approximately 1 mg
protein/mL) were incubated at 37° by shaking (140 rpm), air
being freely admitted, in Tris–HCl/KCl (50 mM/150 mM,
pH 7.4). Ascorbic acid (0.2 mM) and GSH (1 mM) were
neutralised with KOH before addition. Reactions were
started by adding a freshly prepared FeSO4 solution (10
mM). Lipid peroxidation was assayed by measuring thio-
barbituric acid (TBA)-reactive material [1]. Mixing with
ice-cold TBA–trichloroacetic acid (TCA)–HCl–butylhy-
droxytoluene (BHT) solution (2 mL) stopped the reaction in
an aliquot of the incubation mixture (0.3 mL). After heating
(15 min, 80°) and centrifugation (5 min), the absorbance at
535 versus 600 nm was determined. The TBA–TCA–HCl
solution was prepared by dissolving 1.68 g TCA and 41.6
mg TBA in 10 mL 0.125 M HCl. BHT was dissolved in
ethanol (1.5 mg/mL), and 1 mL of this solution was added
to 10 mL TBA–TCA–HCl. The added chemicals did not
interfere with the assay at the concentrations used.
2.6. Determination ofa-tocopherol,a-tocopherol
quinone, and protein
a-Tocopherol anda-tocopherol quinone were extracted
from the membrane to determine the concentration in the
microsomes. The extraction was performed by adding 1 mL
of microsomes to 400mL water, 2 mL ethanol, 10mL
internal standard (a-tocopherol nicotinate, 200mg/mL). Af-
ter shaking for 5 min, 3 mL hexane was added and the
mixture was shaken again (10 min). The hexane layer was
then evaporated and the residue was dissolved in 30mL
isopropylalcohol. The different products were quantified
Fig. 1. Influence of GSH (1 mM) on the time-course of lipid peroxidation
in control microsomes with (. . .) and without (—) addition of GSH. Lipid
peroxidation was induced by ascorbic acid (0.2 mM) and FeSO4 (10 mM).
Lag times, as given in Table 1, were determined as shown in the figure.
Results are shown as the means (6SEM) of three experiments. Inset:
Interaction ofa-tocopherol (a-toc) and GSH in the protection against lipid
peroxidation. Thea-tocopherol radicals (a-tocz) are regenerated toa-to-
copherol by GSH. This reaction is catalysed by a free radical reductase
(FRR).
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using HPLC (Nucleosil 100-5 C18 column, Hewlett-Pack-
ard, eluted with 99% methanol; flow rate 2.0 mL/min) with
diode array detection.a-Tocopherol and thea-tocopherol
nicotinate were quantified using the absorption at 295 nm,
a-tocopherol quinone using the absorption at 270 nm. Mi-
crosomal protein was assayed according to Smithet al. [10],
using BSA as standard.
2.7. Measurement of GSH
The stability of reduced GSH during the incubation was
verified according to the method developed by Ellman [11]
by adding 5,59-dithiobis(2-nitrobenzoic) acid (DTNB, final
concentration 0.6 mM) to 0.1 mM GSH solution incubated
in potassium phosphate buffer (10 mM, pH 7.4) for up to 30
min. Incubations were performed with and without the ad-
dition of 0.1 mM a-tocopherol quinone. The reaction of
GSH with DTNB was allowed to proceed for 5 min, after
which the absorbance at 412 nm was determined. It should
be noted that this assay only measures GSH and not GSSG,
since glutathione reductase is not present.
3. Results
The possible reduction ofa-tocopherol quinone toa-to-
copherol by GSH was examined by adding different con-
centrations of GSH (0.1, 1, and 10 mM) to an-tocopherol
quinone solution (0.1 mM) in buffer. The change in absorp-
tion spectra was examined to monitor the reaction. The
a-tocopherol quinone spectrum did not change within 30
min after addition of GSH, regardless of the GSH concen-
tration, indicating that no reaction had occurred. Fig. 2
shows an example of such a spectrum (the interaction be-
tween 0.1 mM GSH and 0.1 mMa-tocopherol quinone is
depicted). In addition, no GSH consumption, measured by
the non-enzymatic GSH assay, was observed during the
30-min incubation period, confirming that no reaction had
indeed taken place. The strong reductant borohydride
caused the reduction ofa-tocopherol quinone toa-tocoph-
erol hydroquinone, as is also observed in the change in the
absorption spectrum. For comparison, the spectrum ofa-t -
copherol was also depicted.
To further examine the interaction of oxidiseda-tocoph-
erol with GSH, rat liver microsomes were loaded with
a-tocopherol quinone (0.55mM) and the GSH (1 mM)-
induced formation ofa-tocopherol was monitored by HPLC
(approximately 2000 times more GSH than-tocopherol
quinone was present in the microsomes). The membrane
concentrations ofa-tocopherol anda-tocopherol quinone
were not altered by addition of GSH to microsomes fortified
with a-tocopherol quinone. Next, the endogenous vitamin E
was removed from the microsomes by acetone extraction.
After extraction, thea-tocopherol quinone concentration
dropped from 0.23 nmola-tocopherol/mg protein to below
the lower limit of detection (i.e. 0.036 nmola-tocopher-
ol/mg protein). Lipid peroxidation and the effect of GSH on
this process were examined in both these extracted micro-
somes (with or without the addition ofa-tocopherol qui-
none) and in control unextracted microsomes (with or with-
out the addition ofa-tocopherol quinone). Reduction of
a-tocopherol quinone by GSH is expected to increase the
protective effect of GSH against lipid peroxidation. We
studied whether such increased protection really occurred.
The results are listed in Table 1. In Fig. 1, the time-
course of lipid peroxidation in control microsomes is de-
picted to explain how the lag times in Table 1 were ob-
tained. Protection by 1 mM GSH against lipid peroxidation
was clearly visible and resulted in a 14.3-min GSH-induced
lag time in the control microsomes. In the extracted micro-
somes, protection against lipid peroxidation by GSH was
reduced to 6.5 min compared to that in control microsomes.
a-Tocopherol quinone (0.55mM) addition alone had no
effect on iron/ascorbate-induced lipid peroxidation. This
again demonstrates that-tocopherol quinone has no anti-
oxidant activity on its own.a-Tocopherol quinone also had
no effect on the GSH-dependent protection in control mi-
Fig. 2. The UV absorption spectra of an-tocopherol quinone solution (0.1
mM) (blank: spectrum 1) with the addition of GSH (0.1 mM) (spectrum 2)
or NaBH4 (spectrum 3). Spectrum 2 was examined 30 min after the
addition of GSH and spectrum 3 1 min after the addition of NaBH4.
Spectrum 3 was depicted to show that a reduction ina-tocopherol quinone
is indeed possible. Spectrum 4 shows the absorption spectrum of
a-tocopherol.
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crosomes, whereas it completely blocked the GSH-depen-
dent protection in thea-tocopherol-extracted microsomes.
4. Discussion
a-Tocopherol protects against lipid peroxidation. This pro-
tection is achieved via the scavenging of lipid peroxyl radicals
by a-tocopherol. Thea-tocopherol radicals thus formed can be
regenerated in the membrane by cytosolic antioxidants such as
vitamin C or GSH (inset in Fig. 1). Nevertheless, some of the
a-tocopherol radicals will not be captured by this recycling
process and will be oxidised further toa-tocopherol quinone,
which has no antioxidant properties [1,2].
Moore and Ingold [3] have shown that-tocopherol
quinone is reduced toa-tocopherol in man. They concluded
that a-tocopherol quinone might function as an antioxidant
precursor. GSH is one of the likely candidates to serve as
the reductant fora-tocopherol quinone [5]. However, we
found no reduction ina-tocopherol quinone by GSH either
directly in solution or in fortified microsomes (Fig. 2). The
presence of the cytochrome P-450 system in liver micro-
somes, which may serve as a potent source of free radicals,
makes thea-tocopherol present in these microsomes prone
to oxidation. There are several indications that thea-to-
copherol radical, which is formed first, can be regenerated
to a-tocopherol by a free radical reductase that uses GSH
for its reducing equivalents [1,2,4,8]. As shown in this
study, once thea-tocopherol had been oxidised toa-to-
copherol quinone, GSH was not capable of recycling this
oxidised form of a-tocopherol (Fig. 2). Apparently, the
conversion ofa-tocopherol quinone toa-tocopherol ob-
served by Mooreet al. [3] was not due to direct interaction
or to a GSH-dependent reaction witha-tocopherol quinone
in liver microsomes. The results of the lipid peroxidation
experiments confirm that there is no significant conversion
of a-tocopherol quinone toa-tocopherol by GSH in liver
microsomes. If GSH had converteda-tocopherol quinone to
a-tocopherol, the addition ofa-tocopherol quinone toa-to-
copherol-extracted microsomes would have increased the
GSH-dependent lag time.
GSH-dependent protection against lipid peroxidation
was clearly observed in control microsomes (Table 1). A
reduction in thea-tocopherol level by extraction with ace-
tone to a concentration below the limit of detection greatly
reduced GSH-dependent protection against lipid peroxida-
tion [12]. This was expected because GSH-dependent pro-
tection functions in part through reduction of thea-tocoph-
erol radical, and lowering ofa-tocopherol levels decreases
the efficiency of the protection against radicals involved in
lipid peroxidation [1,4,6,13].a-Tocopherol quinone did not
affect GSH-dependent protection in microsomes that con-
taineda-tocopherol (control microsomes), but it did com-
pletely block GSH-dependent protection ina-tocopherol-
depleted microsomes. This implies that-tocopherol
quinone can be toxic to lipid membranes of rat liver micro-
somes when thea-tocopherol concentration is low. A pos-
sible explanation for this effect is that-tocopherol quinone
competes witha-tocopherol for binding to the microsomal
labile free radical reductase, which catalyses the reaction as
shown in the inset in Fig. 1. It has been demonstrated that
this microsomal free radical reductase is not specific for
a-tocopherol and also interacts witha-tocopherol-like com-
ponents [14,15]. Thus,a-tocopherol quinone might block
the interaction ofa-tocopherol with this enzyme. In this
way, a-tocopherol quinone would function as an-tocoph-
erol antagonist. However, such an antagonistic effect of
a-tocopherol quinone is only discerned whena-tocopherol
levels are very low.
It has been shown previously that GSH-dependent pro-
tection is drastically reduced in partly oxidised membranes
[1,2,12]. One possible explanation for this reduction is the
inactivation of the free radical reductase by intermediates
formed during lipid peroxidation [2]. Vitamin E consump-
tion and, as shown in this study, the formation ofa-tocoph-
erol quinone may also contribute to the reduction of GSH-
dependent protection once the process of lipid peroxidation
has started. The antagonistic effect of oxidiseda-tocopherol
on GSH-dependent protection resembles that of oxidised
glutathione, since this oxidised antioxidant also reduces
GSH-dependent protection [5].
In conclusion, GSH is not able to regenerate-tocoph-
erol in rat liver microsomes once it has been oxidised to
a-tocopherol quinone. This implies that there is no positive
effect of a-tocopherol quinone on GSH-dependent protec-
tion against microsomal lipid peroxidation. In contrast,
when thea-tocopherol concentration is low,a-tocopherol
quinone may even reduce GSH-dependent protection, and
thus act as a pro-oxidant.
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